Cedric Gaggioli
Overview
Explore the profile of Cedric Gaggioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
2983
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maiques O, Sallan M, Laddach R, Pandya P, Varela A, Crosas-Molist E, et al.
Nat Commun
. 2025 Feb;
16(1):1394.
PMID: 39952917
The extracellular matrix (ECM) controls tumour dissemination. We characterise ECM organization in human and mouse tumours, identifying three regions: tumour body, proximal invasive front and distal invasive front. Invasive areas...
2.
Thorel L, Perreard M, Florent R, Divoux J, Coffy S, Vincent A, et al.
Exp Mol Med
. 2024 Jun;
56(7):1531-1551.
PMID: 38945959
Over the past decade, the emergence of patient-derived tumor organoids (PDTOs) has broadened the repertoire of preclinical models and progressively revolutionized three-dimensional cell culture in oncology. PDTO can be grown...
3.
Mousset A, Bellone L, Gaggioli C, Albrengues J
Trends Cancer
. 2024 Apr;
10(7):655-667.
PMID: 38664080
Neutrophils, major regulators of innate immunity, have recently emerged as key components of the tumor microenvironment. The role of neutrophils in cancer has been linked to their ability to form...
4.
Mousset A, Bellone L, Gaggioli C, Albrengues J
Med Sci (Paris)
. 2023 Nov;
39(11):827-829.
PMID: 38018924
No abstract available.
5.
Mousset A, Lecorgne E, Bourget I, Lopez P, Jenovai K, Cherfils-Vicini J, et al.
Cancer Cell
. 2023 Apr;
41(4):757-775.e10.
PMID: 37037615
Metastasis is the major cause of cancer death, and the development of therapy resistance is common. The tumor microenvironment can confer chemotherapy resistance (chemoresistance), but little is known about how...
6.
Rovera C, Berestjuk I, Lecacheur M, Tavernier C, Diazzi S, Pisano S, et al.
Cancer Res
. 2022 May;
82(9):1774-1788.
PMID: 35502542
Significance: Communication between dedifferentiated melanoma cells and lymph node fibroblasts reprograms the biomechanical properties of the premetastatic lymph node niche to promote tumor invasion. See related commentary by Lund, p....
7.
Mesenchymal Stem Cells and PRP Therapy Favorize Leak Closure After Sleeve Gastrectomy in Zucker Rats
Benois M, Lecorgne E, Kassir R, Piche M, Ben Amor V, Chenaitia H, et al.
Obes Surg
. 2022 Feb;
32(4):1251-1260.
PMID: 35194771
Introduction: Sleeve gastrectomy (SG) is the most performed bariatric surgery but gastric leaks following SG occur in up to 2% of cases. Regenerative medicine is emerging as a promising field...
8.
Berestjuk I, Lecacheur M, Carminati A, Diazzi S, Rovera C, Prodhomme V, et al.
EMBO Mol Med
. 2021 Dec;
14(2):e11814.
PMID: 34957688
Resistance to BRAF/MEK inhibitor therapy in BRAF -mutated advanced melanoma remains a major obstacle that limits patient benefit. Microenvironment components including the extracellular matrix (ECM) can support tumor cell adaptation...
9.
Jurkute N, Bertacchi M, Arno G, Tocco C, Kim U, Kruszewski A, et al.
Brain Commun
. 2021 Sep;
3(3):fcab162.
PMID: 34466801
Pathogenic variants cause a rare autosomal dominant neurodevelopmental disorder referred to as the Bosch-Boonstra-Schaaf Optic Atrophy Syndrome. Although visual loss is a prominent feature seen in affected individuals, the molecular...
10.
El Mai M, Janho Dit Hreich S, Gaggioli C, Roisin A, Wagner N, Ye J, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34203903
Telomeric repeat-binding factor 2 (TRF2) is a subunit of the shelterin protein complex, which binds to and protects telomeres from unwanted DNA damage response (DDR) activation. TRF2 expression plays a...